Exact Sciences Reports Strong Growth Trajectory for Cologuard™ in First-Quarter 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Exact Sciences Reports Strong Growth Trajectory for Cologuard™ in First-Quarter 2015

Lake Street Capital Markets Downgrades Exact Sciences (EXAS) to Hold

May 5, 2015 9:22 AM EDT

Lake Street Capital Markets downgraded Exact Sciences (NASDAQ: EXAS) from Buy to Hold with a price target of $24.00 (from $28.00). The change follows Q1 results, which were described as slightly better than expected. Analyst Bruce D. Jackson said Cologuard unit ramp and commercial pricing... More

Exact Sciences (EXAS) Tops Q1 EPS by 1c, Company Pleased with Launch Trajectory of Cologuard

May 4, 2015 8:56 AM EDT

Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.40), $0.01 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $4.11 million.

11,000 Cologuard tests were completed and the number of ordering physicians more than doubled,... More